Portolan Capital Management, LLC Nevro Corp Transaction History

Portolan Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$35.43 - $56.29 $1.12 Million - $1.78 Million	-31,605 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$44.22 - $75.47 $66,374 - $113,280	-1,501 Reduced 4.53%	31,605 $1.8 Million
Q2 2018 Aug 14, 2018	SELL	$72.38 - $92.5 $217 - $277	-3 Reduced 0.01%	33,106 $2.64 Million
Q1 2018 May 14, 2018	SELL	$69.46 - $88.57 $15,697 - $20,016	-226 Reduced 0.68%	33,109 $2.87 Million
Q4 2017 Feb 14, 2018	SELL	$65.94 - $93.31 $1.5 Million - $2.12 Million	-22,682 Reduced 40.49%	33,335 $2.3 Million
Q3 2017 Nov 14, 2017	BUY	$80.87 - $91.08 $4.53 Million - $5.1 Million	56,017	56,017 $5.09 Million

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Portolan Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Portolan Capital Management, LLC with notifications on news.